No Data
List of conversion stocks [List of parabolic signal conversion stocks]
○ List of stocks for Buy conversion market Code Stock Name Closing Price SAR Main Board <4587> PD 1916 1675 <4626> Taiyo HD 4680 4285 <7545> Nishimatsuya Chain 2225 2101 ○ List of stocks for Sell conversion market Code Stock Name Closing Price SAR Main Board <2282> Nippon Ham
Express News | [Change Report] M&G Investment Management Limited reported an increase in its shareholding of PeptiDream (4587.JP) to 8.5%.
Sumitomo Electric, Kobayashi Pharmaceutical ETC (Additional) Rating
Target Price Change Code Stock Name Securities Company Previously Changed After-----------------------------------------------<1928> Sekisui House City 4500 yen 3900 yen <2413> M3 GS 2300 yen 2150 yen <3116> Toyota Boshoku GS 2300 yen 2000 yen <3281> GLP Nomura 166000 yen 160000 yen <4151> Kyowa Kirin GS 2500 yen 2400 yen <4483> JMDG GS 47
List of cloud breakout stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud breakout stocks]
○ List of stocks falling below the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1301> Kyokuyo 4155 4176.25 4170 <1762> Takamatsu G 2736 2750 2738.5 <1803> Shimizu Construction 1323 1393.5 1334 <1885> Toa Construction 1287 1343 1298 <1926> Wright Works 2413 2526.5 2425 <1959> Ku
Hot Stocks selected based on technical analysis = Peptidrim, with stochastics turning favorable, exceeding both the 5-day and 25-day moving averages.
On March 31, PeptiDream <4587.T> experienced a rise in its stock price, increasing by 39 yen compared to the previous day with a trading Volume of 800,000 shares. The oscillator indicator, Stochastic, is hovering in the low range of the 10% level, with %D exceeding S%D. Given that it has recovered a positive divergence against both the 5-day and 25-day moving averages at the closing price, it seems to have entered a short-term rebound phase. The weekly chart continues to show a rise in the lower levels, and this week marks a recovery of positive divergence against the 13-week moving average for the first time in three weeks.
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma